BEST SELLER - The 5 Best Ways To Approach KPI Development And Trending
Dr Ben Locwin has been an executive in the pharmaceutical industry and the healthcare industry, playing a key role in the development and implementation of Regulatory and Quality guidance for over 20 years. In this time, he has also consulted for many of the Top 10 pharma companies, as well as having been involved in several successful biotech and pharma startups, who were looking to successfully achieve market approval for their new therapeutic products. He has also taught programs on Evidence-Based Medicine to hospital systems and clinical centres in the US and Europe. Dr Locwin has been featured in top media such as The Wall Street Journal, Forbes, USA Today, The Associated Press, and many others.
In this course, you will hear from industry leader Dr Locwin discuss the best methodologies to employ in initial KPI development, as well as practical approaches and tools for monitoring KPIs for adverse trends.
Key Performance Indicators (KPIs) are used in every major company across the world that has achieved any level of success, and with good reason – You can’t know where to invest next to improve the future if you don’t have proper measures of where you are ‘now’!
Unfortunately, many companies purvey totally useless, spurious, and erroneous KPIs to drive internal business decision-making. The reason why you don’t hear about this more often in business intelligence publications is that corporations don’t collect data on their own internal flaws with designing KPIs and how they perform (actual) versus what they expected. This would drive their shareholders mad! Though in actual fact, shareholders would love to know this information – it would make their investment decisions that much more accurate and timely.
By properly defining business needs, internal processes, and performance outcomes, your organization can benefit from much more scientific management of resources and better decision-making.
- Which KPIs work well, and which are frequently-used, but in actual fact uninformative
- How use of KPIs has changed over the past 2 decades, and where the industry is at now
- KPIs that frequently lead to FDA inquiries and potential enforcement action
- The most common mistakes companies make when trending KPIs
Who Should Attend
Level 1: Quality Assurance, Quality Control, Compliance, Regulatory
Level 2: VPs, Directors, Managers, Specialists, Analysts